This website uses cookies to enhance the user experience.
G

GULLA HOLDING AS994 829 807

Research
Limited company
Ole Bulls vei 6 1410 KOLBOTN, Norge

GULLA HOLDING AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO
Chairman of the board
Years since formation
15 years
since Dec 5, 2009
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
115,575
1 share class
Total number of shareholders
1
person
Belongs to group of

Financials

Annual total result 2023
486,808
NOK
Total equity 2023
7,041,532
NOK
Last update: Sep 9, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
directly

Board

NameRoleShares
Chairman
100 %
directly
Board Member-

Others

NameRoleShares
P
PRAVDA ACCOUNTING AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
directly
Last update: Apr 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
115,575
100 %

Shares owned by the GULLA HOLDING AS

NameShare classNumber of sharesShare
A
AKVAPROSJEKTER AS
Ordinary shares
100,000
100 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 0
    Operating profit 2023: NOK -8,728
    Employees: 0

Financials

in NOK

Summary

Year202320222021
Total operating income
0
0
0
Annual Total Result
486,808
239,280
3,968,509
Total assets
7,179,031
6,611,907
6,431,019
Total liabilities
137,499
57,183
0
Total equity
7,041,532
6,554,724
6,431,019

P&L

Year202320222021
Total operating income
0
0
0
Total operating costs
8,728
56,248
13,491
Operating result
-8,728
-56,248
-13,491
Financial income/costs
633,035
352,711
3,982,000
Profit before tax
624,307
296,463
3,968,509
Total tax & extraordinary income/cost
137,499
57,183
0
Annual Total Result
486,808
239,280
3,968,509

Balance overview

Year202320222021
Total fixed assets
7,173,486
6,509,763
2,289,955
Total current assets
5,546
102,144
4,141,064
Total assets
7,179,031
6,611,907
6,431,019
Short term debt
137,499
57,183
0
Long term debt
0
0
0
Total liabilities
137,499
57,183
0
Contributed capital
129,325
129,325
244,900
Retained earnings
6,912,207
6,425,399
6,186,119
Total equity
7,041,532
6,554,724
6,431,019
Total equity and liabilities
7,179,031
6,611,907
6,431,019

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology